Risky business – Understanding and managing residual CVD risk
This webinar will explore the latest evidence on managing residual cardiovascular risk supported by a case study and include practical tools and resources to optimise CVD risk factor management within primary healthcare.
Discussion will include:
- Current guideline-based management strategies for CVD risk reduction, including BP, lipids, diabetes medicines, antiplatelets.
- Lipid subfractions, such as Lp(a) and their use in clinical practice for risk identification and update on emerging treatments.
- Key genetic determinants of CVD and how polygenic risk can be utilised to enhance traditional screening strategies.
- Inflammatory, thrombotic and diabetes considerations for residual CVD risk.
- A case study illustrating the practical application of approaches to managing residual risk in primary care.